A research team has elucidated the mechanism behind bacterial cancer therapy using a genetically engineered bacterial strain. Their findings were published in Cell.

with efficacy depending on the high expression of interleukin-10 receptor (IL-10R) on CD8 + TRM cells. To examine the source of IL-10 within the tumor microenvironment (TME) after bacterial ...